STAT+: A strong start for Madrigal’s MASH drug launch
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Category: Medicine
STAT+: Pharmalittle: We’re reading about a Purdue overdose-reversal device, a discontinued Merck trial, and more
Top of the morning to you, and a fine one it is, despite the gray…
STAT+: AI drug developers Recursion, Exscientia to merge
Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia,…
Sarepta CEO: We’re ‘pretty brilliant’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Eli Lilly boosts 2024 revenue guidance by $3 billion on Mounjaro, Zepbound sales
Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of…
Opinion: Removing barriers to split liver transplants will save lives
The liver is one of the few organs that need not be transplanted whole. It…
Scientists are starting to uncover how neighborhood can affect the biology of cancer
Where you live has a relationship to your odds of getting cancer and surviving cancer….
Trump’s real health care agenda isn’t in Project 2025 — it’s in his own words
WASHINGTON — Former President Trump has made it abundantly clear that nobody else speaks for…
Watch: How drug patents pave the way to profit
This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex…
STAT+: Orlando Health, a $6 billion Florida powerhouse, is expanding into Alabama
As for-profit Tenet Healthcare slims its hospital portfolio, it found an unlikely buyer for its…
FDA approves Purdue Pharma’s controversial new overdose-reversal medication
Purdue Pharma, the company best known for fueling the opioid crisis by misleadingly marketing the…
STAT+: Vertex, U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England
LONDON — Patients in England with a rare blood disorder will now be able to…
STAT+: Medicare finalizes reimbursement rule for breakthrough medical devices
The Centers for Medicare and Medicaid Services has finalized its rule easing reimbursement for medical…
The dark side of Medicare Advantage: a must-read investigation
Dear Readers, If you read anything this year exposing the hidden injustices in our health…
STAT+: CVS removes top Aetna leader as higher medical costs eat further into profits
CVS Health continued to pay out more than it expected for the medical claims of…
STAT+: The race to build better CRISPR delivery vehicles is heating up
If the first CRISPR decade was marked by a mad dash to evolve, engineer, and…
STAT+: FDA scolds Bristol Myers over a misleading website for a cancer treatment
The U.S. Food and Drug Administration has scolded Bristol Myers Squibb for making false and…
WHO to convene panel to determine whether mpox outbreak is a public health emergency
The director general of the World Health Organization announced Wednesday that he will convene a…
STAT+: Pharmalittle: We’re reading about Roche plans for Flatiron, underwhelming Novo Nordisk earnings, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
STAT+: Novo Nordisk pulls filings for Wegovy in heart failure as it waits for cardiovascular outcomes data
Novo Nordisk is pulling its regulatory submissions to expand the use of its obesity drug…
A new drug for glioma means a windfall for Agios
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Trump keeps losing his train of thought. Cognitive experts have theories about why
In a speech earlier this year, former President Trump was mocking President Biden’s ability to…
Opinion: Give pharmaceutical execs the benefit of doubt — but they need to work for it
The polarized debate over drug pricing has generated cartoonish, sometimes colorful caricatures of the biopharmaceutical…
STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine
The nation’s largest health care company pressed thousands of its clinicians to use a thinly…
Opinion: When life mirrors research: What a fall on the ice taught me about being Black and in pain
As I hurried to an important meeting about my Ph.D. dissertation one day in 2015,…
STAT+: Supply issues weigh on Novo Nordisk as drugmaker stumbles with quarterly report
LONDON — An underwhelming earnings report and ongoing questions about increasing competition in the booming…
Why Tim Walz’ record on Covid-19 will be a hot-button issue in 2024
WASHINGTON — After news broke that Vice President Kamala Harris had officially selected Tim Walz…
STAT+: Tim Walz stood up to corporate health care. Mayo Clinic was a powerful exception.
MINNEAPOLIS — Even for the most progressive of politicians, money talks. And elite nonprofit hospitals…
FDA’s digital health advisory committee takes shape, and a critique of cost-effectiveness studies
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
Harris’ reported running mate, Minnesota Governor Tim Walz, boasts progressive health care record
WASHINGTON — With Minnesota Gov. Tim Walz as her running mate, Vice President Kamala Harris…
The exclusive biotech stories you need to read
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a canceled Roche trial, low VC biotech funding, and more
Top of the morning to you. Another steamy day is unfolding here at the Pharmalot…
STAT+: Biotech mogul Arie Belldegrun extends empire with launch of $600 million credit firm
Arie Belldegrun has yet another job: He wants to be your lender. On Tuesday, Belledegrun…
STAT+: Former Biden White House health official joins Flagship Pioneering
WASHINGTON — Raj Panjabi has made a career out of taking on some of public…
STAT+: ‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers
Roche, the Swiss pharmaceutical giant, earlier this year abruptly cancelled an international clinical trial of…
Opinion: Congress is unprepared for the post-Chevron world. It needs help from subject matter experts
The U.S. Congress needs help. It lacks the expertise to do its job in the…
Opinion: How the restaurant drama ‘The Bear’ mirrors working in a hospital
Many chefs describe the television series “The Bear” as an accurate portrayal of the demands…
STAT+: Biotech VCs are pacing for another record-low year of fundraising amid glimpses of recovery
Life science venture capital firms are pacing for another record-low year of fundraising, potentially hindering…
STAT+: Jeff Shuren stabilized the FDA’s medical devices center, winning over industry but not all patients
Retirements from the Food and Drug Administration are hardly shocking, especially in the wake of…
STAT+: Lawmakers cast doubt on expert panel studying alcohol for 2025 dietary guidelines
Alcohol policy researchers are fuming over a letter sent by members of Congress last month,…
Millions of people became uninsured as Medicaid programs cut coverage, new data show
The national uninsured rate rose from 7.7% to 8.2% earlier this year, a result of…
STAT+: BioMarin to restrict sales of hemophilia gene therapy, seeking to overcome slow sales
Struggling to find new patients, BioMarin Pharmaceuticals on Monday said it would restrict sales of…
More heart patients getting prompt post-hospital care, but disparities increase
Recovery from a cardiac-related hospitalization requires coordinated, timely care to prevent a return to the…
STAT+: North Carolina urges HHS to license Novo and Lilly obesity drugs as a way to lower costs
Frustrated by the lack of access to expensive weight loss drugs, North Carolina officials are…
Opinion: Cost-effectiveness of health interventions may be perpetuating health disparities. Here’s how to fix that
As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized…
The infectious disease doctor shortage will hit marginalized people the hardest
The Covid-19 pandemic underscored the importance of infectious disease doctors — but the field is…
STAT+: Pharmalittle: We’re reading about MDMA trials, weight loss drug availability, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Morning Rounds: The ‘very risky business’ of buying weight loss drugs online
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
FDA ad comm favors Zevra’s Niemann-Pick drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medicare scrambles to keep prescription drug plan premiums stable ahead of elections
WASHINGTON — Medicare officials are offering private insurers big subsidies to keep premiums for prescription-drug…